On this page
Meruvax Ii
Rubella Virus Vaccine Live
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Meruvax Ii
Proper name
Rubella Virus Vaccine Live
Licence type
351(a)
BLA number
101075
Applicant
Merck Sharp & Dohme LLC
Center
CBER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| NLT1000U/.5ML | For Injection | Subcutaneous | Vial | Disc | June 9, 1969 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |